Global Quetiapine Fumarate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 112
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Quetiapine Fumarate market size was valued at USD 164.3 million in 2023 and is forecast to a readjusted size of USD 141.6 million by 2030 with a CAGR of -2.1% during review period.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
The Global Info Research report includes an overview of the development of the Quetiapine Fumarate industry chain, the market status of Adult (Immediate Release Tablets, Extended Release Tablets), Others (Immediate Release Tablets, Extended Release Tablets), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Quetiapine Fumarate.
Regionally, the report analyzes the Quetiapine Fumarate markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Quetiapine Fumarate market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Quetiapine Fumarate market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Quetiapine Fumarate industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., Immediate Release Tablets, Extended Release Tablets).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Quetiapine Fumarate market.
Regional Analysis: The report involves examining the Quetiapine Fumarate market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Quetiapine Fumarate market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Quetiapine Fumarate:
Company Analysis: Report covers individual Quetiapine Fumarate manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Quetiapine Fumarate This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adult, Others).
Technology Analysis: Report covers specific technologies relevant to Quetiapine Fumarate. It assesses the current state, advancements, and potential future developments in Quetiapine Fumarate areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Quetiapine Fumarate market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Quetiapine Fumarate market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Immediate Release Tablets
Extended Release Tablets
Market segment by Application
Adult
Others
Major players covered
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quetiapine Fumarate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quetiapine Fumarate, with price, sales, revenue and global market share of Quetiapine Fumarate from 2019 to 2024.
Chapter 3, the Quetiapine Fumarate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quetiapine Fumarate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Quetiapine Fumarate market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quetiapine Fumarate.
Chapter 14 and 15, to describe Quetiapine Fumarate sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Quetiapine Fumarate
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Quetiapine Fumarate Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immediate Release Tablets
1.3.3 Extended Release Tablets
1.4 Market Analysis by Application
1.4.1 Overview: Global Quetiapine Fumarate Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Adult
1.4.3 Others
1.5 Global Quetiapine Fumarate Market Size & Forecast
1.5.1 Global Quetiapine Fumarate Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Quetiapine Fumarate Sales Quantity (2019-2030)
1.5.3 Global Quetiapine Fumarate Average Price (2019-2030)
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Quetiapine Fumarate Product and Services
2.1.4 AstraZeneca Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Intas
2.2.1 Intas Details
2.2.2 Intas Major Business
2.2.3 Intas Quetiapine Fumarate Product and Services
2.2.4 Intas Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Intas Recent Developments/Updates
2.3 TAPI
2.3.1 TAPI Details
2.3.2 TAPI Major Business
2.3.3 TAPI Quetiapine Fumarate Product and Services
2.3.4 TAPI Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TAPI Recent Developments/Updates
2.4 Accord
2.4.1 Accord Details
2.4.2 Accord Major Business
2.4.3 Accord Quetiapine Fumarate Product and Services
2.4.4 Accord Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Accord Recent Developments/Updates
2.5 Hexal
2.5.1 Hexal Details
2.5.2 Hexal Major Business
2.5.3 Hexal Quetiapine Fumarate Product and Services
2.5.4 Hexal Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Hexal Recent Developments/Updates
2.6 Dr.Reddy's
2.6.1 Dr.Reddy's Details
2.6.2 Dr.Reddy's Major Business
2.6.3 Dr.Reddy's Quetiapine Fumarate Product and Services
2.6.4 Dr.Reddy's Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Dr.Reddy's Recent Developments/Updates
2.7 Lupin
2.7.1 Lupin Details
2.7.2 Lupin Major Business
2.7.3 Lupin Quetiapine Fumarate Product and Services
2.7.4 Lupin Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Lupin Recent Developments/Updates
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Quetiapine Fumarate Product and Services
2.8.4 Sun Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sun Pharmaceutical Recent Developments/Updates
2.9 Hunan Dongting Pharm
2.9.1 Hunan Dongting Pharm Details
2.9.2 Hunan Dongting Pharm Major Business
2.9.3 Hunan Dongting Pharm Quetiapine Fumarate Product and Services
2.9.4 Hunan Dongting Pharm Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hunan Dongting Pharm Recent Developments/Updates
2.10 SuZhou NO.4 Phamaceutical Factory
2.10.1 SuZhou NO.4 Phamaceutical Factory Details
2.10.2 SuZhou NO.4 Phamaceutical Factory Major Business
2.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product and Services
2.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
2.11 Fuan Pharmaceutical
2.11.1 Fuan Pharmaceutical Details
2.11.2 Fuan Pharmaceutical Major Business
2.11.3 Fuan Pharmaceutical Quetiapine Fumarate Product and Services
2.11.4 Fuan Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Fuan Pharmaceutical Recent Developments/Updates
2.12 Zhejiang Supor Pharmaceuticals
2.12.1 Zhejiang Supor Pharmaceuticals Details
2.12.2 Zhejiang Supor Pharmaceuticals Major Business
2.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product and Services
2.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zhejiang Supor Pharmaceuticals Recent Developments/Updates
2.13 Zhejiang Huahai Pharmaceutical
2.13.1 Zhejiang Huahai Pharmaceutical Details
2.13.2 Zhejiang Huahai Pharmaceutical Major Business
2.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product and Services
2.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
3.1 Global Quetiapine Fumarate Sales Quantity by Manufacturer (2019-2024)
3.2 Global Quetiapine Fumarate Revenue by Manufacturer (2019-2024)
3.3 Global Quetiapine Fumarate Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Quetiapine Fumarate by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Quetiapine Fumarate Manufacturer Market Share in 2023
3.4.2 Top 6 Quetiapine Fumarate Manufacturer Market Share in 2023
3.5 Quetiapine Fumarate Market: Overall Company Footprint Analysis
3.5.1 Quetiapine Fumarate Market: Region Footprint
3.5.2 Quetiapine Fumarate Market: Company Product Type Footprint
3.5.3 Quetiapine Fumarate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Quetiapine Fumarate Market Size by Region
4.1.1 Global Quetiapine Fumarate Sales Quantity by Region (2019-2030)
4.1.2 Global Quetiapine Fumarate Consumption Value by Region (2019-2030)
4.1.3 Global Quetiapine Fumarate Average Price by Region (2019-2030)
4.2 North America Quetiapine Fumarate Consumption Value (2019-2030)
4.3 Europe Quetiapine Fumarate Consumption Value (2019-2030)
4.4 Asia-Pacific Quetiapine Fumarate Consumption Value (2019-2030)
4.5 South America Quetiapine Fumarate Consumption Value (2019-2030)
4.6 Middle East and Africa Quetiapine Fumarate Consumption Value (2019-2030)
5.1 Global Quetiapine Fumarate Sales Quantity by Type (2019-2030)
5.2 Global Quetiapine Fumarate Consumption Value by Type (2019-2030)
5.3 Global Quetiapine Fumarate Average Price by Type (2019-2030)
6.1 Global Quetiapine Fumarate Sales Quantity by Application (2019-2030)
6.2 Global Quetiapine Fumarate Consumption Value by Application (2019-2030)
6.3 Global Quetiapine Fumarate Average Price by Application (2019-2030)
7.1 North America Quetiapine Fumarate Sales Quantity by Type (2019-2030)
7.2 North America Quetiapine Fumarate Sales Quantity by Application (2019-2030)
7.3 North America Quetiapine Fumarate Market Size by Country
7.3.1 North America Quetiapine Fumarate Sales Quantity by Country (2019-2030)
7.3.2 North America Quetiapine Fumarate Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Quetiapine Fumarate Sales Quantity by Type (2019-2030)
8.2 Europe Quetiapine Fumarate Sales Quantity by Application (2019-2030)
8.3 Europe Quetiapine Fumarate Market Size by Country
8.3.1 Europe Quetiapine Fumarate Sales Quantity by Country (2019-2030)
8.3.2 Europe Quetiapine Fumarate Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Quetiapine Fumarate Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Quetiapine Fumarate Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Quetiapine Fumarate Market Size by Region
9.3.1 Asia-Pacific Quetiapine Fumarate Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Quetiapine Fumarate Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Quetiapine Fumarate Sales Quantity by Type (2019-2030)
10.2 South America Quetiapine Fumarate Sales Quantity by Application (2019-2030)
10.3 South America Quetiapine Fumarate Market Size by Country
10.3.1 South America Quetiapine Fumarate Sales Quantity by Country (2019-2030)
10.3.2 South America Quetiapine Fumarate Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Quetiapine Fumarate Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Quetiapine Fumarate Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Quetiapine Fumarate Market Size by Country
11.3.1 Middle East & Africa Quetiapine Fumarate Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Quetiapine Fumarate Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Quetiapine Fumarate Market Drivers
12.2 Quetiapine Fumarate Market Restraints
12.3 Quetiapine Fumarate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Quetiapine Fumarate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Quetiapine Fumarate
13.3 Quetiapine Fumarate Production Process
13.4 Quetiapine Fumarate Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Quetiapine Fumarate Typical Distributors
14.3 Quetiapine Fumarate Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Quetiapine Fumarate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Quetiapine Fumarate Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Quetiapine Fumarate Product and Services
Table 6. AstraZeneca Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Intas Basic Information, Manufacturing Base and Competitors
Table 9. Intas Major Business
Table 10. Intas Quetiapine Fumarate Product and Services
Table 11. Intas Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Intas Recent Developments/Updates
Table 13. TAPI Basic Information, Manufacturing Base and Competitors
Table 14. TAPI Major Business
Table 15. TAPI Quetiapine Fumarate Product and Services
Table 16. TAPI Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. TAPI Recent Developments/Updates
Table 18. Accord Basic Information, Manufacturing Base and Competitors
Table 19. Accord Major Business
Table 20. Accord Quetiapine Fumarate Product and Services
Table 21. Accord Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Accord Recent Developments/Updates
Table 23. Hexal Basic Information, Manufacturing Base and Competitors
Table 24. Hexal Major Business
Table 25. Hexal Quetiapine Fumarate Product and Services
Table 26. Hexal Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Hexal Recent Developments/Updates
Table 28. Dr.Reddy's Basic Information, Manufacturing Base and Competitors
Table 29. Dr.Reddy's Major Business
Table 30. Dr.Reddy's Quetiapine Fumarate Product and Services
Table 31. Dr.Reddy's Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Dr.Reddy's Recent Developments/Updates
Table 33. Lupin Basic Information, Manufacturing Base and Competitors
Table 34. Lupin Major Business
Table 35. Lupin Quetiapine Fumarate Product and Services
Table 36. Lupin Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Lupin Recent Developments/Updates
Table 38. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceutical Major Business
Table 40. Sun Pharmaceutical Quetiapine Fumarate Product and Services
Table 41. Sun Pharmaceutical Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Sun Pharmaceutical Recent Developments/Updates
Table 43. Hunan Dongting Pharm Basic Information, Manufacturing Base and Competitors
Table 44. Hunan Dongting Pharm Major Business
Table 45. Hunan Dongting Pharm Quetiapine Fumarate Product and Services
Table 46. Hunan Dongting Pharm Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Hunan Dongting Pharm Recent Developments/Updates
Table 48. SuZhou NO.4 Phamaceutical Factory Basic Information, Manufacturing Base and Competitors
Table 49. SuZhou NO.4 Phamaceutical Factory Major Business
Table 50. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product and Services
Table 51. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. SuZhou NO.4 Phamaceutical Factory Recent Developments/Updates
Table 53. Fuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Fuan Pharmaceutical Major Business
Table 55. Fuan Pharmaceutical Quetiapine Fumarate Product and Services
Table 56. Fuan Pharmaceutical Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Fuan Pharmaceutical Recent Developments/Updates
Table 58. Zhejiang Supor Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Supor Pharmaceuticals Major Business
Table 60. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product and Services
Table 61. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zhejiang Supor Pharmaceuticals Recent Developments/Updates
Table 63. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Zhejiang Huahai Pharmaceutical Major Business
Table 65. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product and Services
Table 66. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales Quantity (MT), Average Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 68. Global Quetiapine Fumarate Sales Quantity by Manufacturer (2019-2024) & (MT)
Table 69. Global Quetiapine Fumarate Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Quetiapine Fumarate Average Price by Manufacturer (2019-2024) & (USD/Kg)
Table 71. Market Position of Manufacturers in Quetiapine Fumarate, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Quetiapine Fumarate Production Site of Key Manufacturer
Table 73. Quetiapine Fumarate Market: Company Product Type Footprint
Table 74. Quetiapine Fumarate Market: Company Product Application Footprint
Table 75. Quetiapine Fumarate New Market Entrants and Barriers to Market Entry
Table 76. Quetiapine Fumarate Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Quetiapine Fumarate Sales Quantity by Region (2019-2024) & (MT)
Table 78. Global Quetiapine Fumarate Sales Quantity by Region (2025-2030) & (MT)
Table 79. Global Quetiapine Fumarate Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Quetiapine Fumarate Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Quetiapine Fumarate Average Price by Region (2019-2024) & (USD/Kg)
Table 82. Global Quetiapine Fumarate Average Price by Region (2025-2030) & (USD/Kg)
Table 83. Global Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 84. Global Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 85. Global Quetiapine Fumarate Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Quetiapine Fumarate Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Quetiapine Fumarate Average Price by Type (2019-2024) & (USD/Kg)
Table 88. Global Quetiapine Fumarate Average Price by Type (2025-2030) & (USD/Kg)
Table 89. Global Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 90. Global Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 91. Global Quetiapine Fumarate Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Quetiapine Fumarate Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Quetiapine Fumarate Average Price by Application (2019-2024) & (USD/Kg)
Table 94. Global Quetiapine Fumarate Average Price by Application (2025-2030) & (USD/Kg)
Table 95. North America Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 96. North America Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 97. North America Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 98. North America Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 99. North America Quetiapine Fumarate Sales Quantity by Country (2019-2024) & (MT)
Table 100. North America Quetiapine Fumarate Sales Quantity by Country (2025-2030) & (MT)
Table 101. North America Quetiapine Fumarate Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Quetiapine Fumarate Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 104. Europe Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 105. Europe Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 106. Europe Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 107. Europe Quetiapine Fumarate Sales Quantity by Country (2019-2024) & (MT)
Table 108. Europe Quetiapine Fumarate Sales Quantity by Country (2025-2030) & (MT)
Table 109. Europe Quetiapine Fumarate Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Quetiapine Fumarate Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 112. Asia-Pacific Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 113. Asia-Pacific Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 114. Asia-Pacific Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 115. Asia-Pacific Quetiapine Fumarate Sales Quantity by Region (2019-2024) & (MT)
Table 116. Asia-Pacific Quetiapine Fumarate Sales Quantity by Region (2025-2030) & (MT)
Table 117. Asia-Pacific Quetiapine Fumarate Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Quetiapine Fumarate Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 120. South America Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 121. South America Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 122. South America Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 123. South America Quetiapine Fumarate Sales Quantity by Country (2019-2024) & (MT)
Table 124. South America Quetiapine Fumarate Sales Quantity by Country (2025-2030) & (MT)
Table 125. South America Quetiapine Fumarate Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Quetiapine Fumarate Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Quetiapine Fumarate Sales Quantity by Type (2019-2024) & (MT)
Table 128. Middle East & Africa Quetiapine Fumarate Sales Quantity by Type (2025-2030) & (MT)
Table 129. Middle East & Africa Quetiapine Fumarate Sales Quantity by Application (2019-2024) & (MT)
Table 130. Middle East & Africa Quetiapine Fumarate Sales Quantity by Application (2025-2030) & (MT)
Table 131. Middle East & Africa Quetiapine Fumarate Sales Quantity by Region (2019-2024) & (MT)
Table 132. Middle East & Africa Quetiapine Fumarate Sales Quantity by Region (2025-2030) & (MT)
Table 133. Middle East & Africa Quetiapine Fumarate Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Quetiapine Fumarate Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Quetiapine Fumarate Raw Material
Table 136. Key Manufacturers of Quetiapine Fumarate Raw Materials
Table 137. Quetiapine Fumarate Typical Distributors
Table 138. Quetiapine Fumarate Typical Customers
List of Figures
Figure 1. Quetiapine Fumarate Picture
Figure 2. Global Quetiapine Fumarate Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Quetiapine Fumarate Consumption Value Market Share by Type in 2023
Figure 4. Immediate Release Tablets Examples
Figure 5. Extended Release Tablets Examples
Figure 6. Global Quetiapine Fumarate Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Quetiapine Fumarate Consumption Value Market Share by Application in 2023
Figure 8. Adult Examples
Figure 9. Others Examples
Figure 10. Global Quetiapine Fumarate Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Quetiapine Fumarate Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Quetiapine Fumarate Sales Quantity (2019-2030) & (MT)
Figure 13. Global Quetiapine Fumarate Average Price (2019-2030) & (USD/Kg)
Figure 14. Global Quetiapine Fumarate Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Quetiapine Fumarate Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Quetiapine Fumarate by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Quetiapine Fumarate Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Quetiapine Fumarate Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Quetiapine Fumarate Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Quetiapine Fumarate Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Quetiapine Fumarate Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Quetiapine Fumarate Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Quetiapine Fumarate Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Quetiapine Fumarate Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Quetiapine Fumarate Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Quetiapine Fumarate Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Quetiapine Fumarate Average Price by Type (2019-2030) & (USD/Kg)
Figure 29. Global Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Quetiapine Fumarate Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Quetiapine Fumarate Average Price by Application (2019-2030) & (USD/Kg)
Figure 32. North America Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Quetiapine Fumarate Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Quetiapine Fumarate Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Quetiapine Fumarate Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Quetiapine Fumarate Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Quetiapine Fumarate Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Quetiapine Fumarate Consumption Value Market Share by Region (2019-2030)
Figure 52. China Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Quetiapine Fumarate Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Quetiapine Fumarate Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Quetiapine Fumarate Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Quetiapine Fumarate Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Quetiapine Fumarate Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Quetiapine Fumarate Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Quetiapine Fumarate Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Quetiapine Fumarate Market Drivers
Figure 73. Quetiapine Fumarate Market Restraints
Figure 74. Quetiapine Fumarate Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Quetiapine Fumarate in 2023
Figure 77. Manufacturing Process Analysis of Quetiapine Fumarate
Figure 78. Quetiapine Fumarate Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AstraZeneca Intas TAPI Accord Hexal Dr.Reddy's Lupin Sun Pharmaceutical Hunan Dongting Pharm SuZhou NO.4 Phamaceutical Factory Fuan Pharmaceutical Zhejiang Supor Pharmaceuticals Zhejiang Huahai Pharmaceutical
Related Reports
18 Mar 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
